Findings from the main studies
Semaglutide research: what changed for people
Semaglutide may bring down sugar and ease hunger. You'll see results from large weight, heart, kidney, and early drinking studies.
What Semaglutide research can tell you
Doctors prescribe Semaglutide in diabetes and weight care. You'll see what happened across studies involving many thousands of people.
The medicine copies GLP-1, a hormone your gut makes at mealtime. It steadies sugar and helps you recognize a full meal. Your body removes its own supply in about two minutes. One Semaglutide dose works for seven days [12].
Large trials found major weight loss [1]. They also counted fewer heart attacks and strokes [3]. People with diabetes saw kidney disease worsen more slowly [6]. Early work hasn't settled the drinking question [8].
Over coffee, I'd keep firm proof well apart from an early hint, because you deserve to know where confidence ends and honest doubt begins before you make a health choice. You'll see that split in each section. Tirzepatide's result is here too.
What Semaglutide is meant to do
Semaglutide is meant to steady sugar and ease hunger. GLP-1 is the name of the gut hormone it imitates. The medicine is 94% like human GLP-1 [12]. Natural GLP-1 fades within minutes, while Semaglutide doesn't.
Two small changes make each dose last. One protects it from being torn apart too soon. Another lets it travel beside a common blood protein [12]. Researchers mark one drug part as 8 and one body chemical as 4. They aren't doses, times, or steps for you. Half remains one week later. By about five weeks after the final dose, nearly all is gone [12].
After meals, the copied hormone helps your pancreas add insulin. Semaglutide is one of the GLP-1 medicines. Approved forms are a daily tablet and a weekly shot into the fatty layer beneath skin [11]. You don't need the long lab names to use either form safely.
How does Semaglutide work after a meal
After you eat, Semaglutide makes three changes. The pancreas adds insulin only after sugar has climbed [12]. Used alone, the medicine is less likely to push sugar too low. It cuts a different hormone that drives sugar upward [12]. Your stomach also holds food longer before sending it onward [12].
The brain may drive much of the weight result. Researchers found Semaglutide in hunger and fullness areas of rats and mice. The stop-eating message grew stronger. Those animals chose different food and ate less, but they didn't burn fewer calories [4].
The same brain areas may bear on the early alcohol finding. You can't count on losing interest in drink, and you'll need firmer studies before trusting that idea.
What the largest Semaglutide trials found
Semaglutide weight loss
STEP 1 enrolled 1,961 heavy adults without diabetes. Each week, they received 2.4 mg or a drug-free shot. By 68 weeks, average loss with Semaglutide equaled 14.9% of starting weight. The other group lost 2.4%. The difference was 12.4 percentage points [1]. You'll know an average can't promise your result.
What the large heart studies found. SUSTAIN-6 included people with type 2 diabetes whose hearts were already at great risk. In SUSTAIN-6, they received either 0.5 or 1.0 mg each week. Heart death, a heart attack that didn't kill them, or a stroke that didn't kill them occurred less often. The first 95% study check showed that normal doubt didn't erase the heart finding. Diabetic eye trouble rose, and the second 95% check didn't erase that concern [2]. You have heart help paired with an eye concern.
A second trial followed 17,604 heavy people. Every person had heart disease, and none had diabetes. With 2.4 mg each week, major heart trouble occurred 20% less often than in the placebo group. Its 95% check didn't erase the heart finding [3].
What the large kidney study found. It enrolled 3,533 people who had both type 2 diabetes and kidney disease that wasn't going away. With 1.0 mg each week, major kidney trouble fell 24%. That meant kidney failure, a 50%-or-greater drop in a kidney blood test, or death linked with kidney or heart illness. The 95% check didn't erase the drop in grave kidney problems [6].
How Semaglutide vs tirzepatide changed weight
A study called SURMOUNT-5 directly compared the medicines in 751 heavy people. At 72 weeks, average weight loss was 20.2% with tirzepatide and 13.7% with Semaglutide. The gap was about 6.5 percentage points, and the study found it was unlikely to be chance [7].
That result doesn't erase the Semaglutide finding. Its 13.7% loss agrees with other STEP work [1]. Semaglutide also has its own heart and kidney findings [3][6]. You can weigh those facts beside the greater average loss with tirzepatide, and you'll know the averages aren't promises.
The medicines copy different gut hormones. Tirzepatide copies two of them. Semaglutide copies only GLP-1. Researchers think copying two hormones could partly account for the weight gap, but they haven't settled every reason.
What newer Semaglutide studies found about alcohol and muscle
Alcohol use disorder. A phase-2 trial, an early test rather than final proof, assigned 48 adults by chance to low-dose Semaglutide or placebo. The people given Semaglutide drank less in a planned test. A standard 95% study check found that ordinary doubt didn't erase the drinking result. Heavy-drinking days also seemed to fall over nine weeks [8]. Rats drank less in another study, and the medicine changed their brain response to reward [9]. A review of GLP-1 medicines, drugs that imitate a gut hormone, called the work hopeful but asked for bigger trials [10]. The semaglutide and alcohol page explains why this isn't proof of treatment.
Fat and muscle. A small set of scans in a weight trial found muscle loss along with fat loss [13]. New studies are asking whether food protein and strength-building exercise can help guard muscle. The semaglutide muscle loss page explains why age matters.
Reports after approval. Most safety reports from public use involved the stomach or bowels [18]. Reports can warn you about a possible harm, so you'll know what to ask, but they can't prove that Semaglutide caused it.
What Semaglutide studies still haven't settled
More than one large study found weight loss with Semaglutide. A heart study called SUSTAIN-6 followed people with diabetes, while another followed people without it [2][3]. Repeated findings make the results firmer, though they don't remove every doubt.
Important questions remain. The alcohol trial was small and early [8]. A small set of scans found muscle loss, but the study didn't test whether people grew weaker [13]. Some possible harms in safety reports still haven't been confirmed [5].
For you, the useful split is simple, and you'll be able to see whether a study proves a change, hints at one, or leaves the question open.